275 related articles for article (PubMed ID: 30639794)
1. PrEP awareness, eligibility, and interest among people who inject drugs in Baltimore, Maryland.
Sherman SG; Schneider KE; Park JN; Allen ST; Hunt D; Chaulk CP; Weir BW
Drug Alcohol Depend; 2019 Feb; 195():148-155. PubMed ID: 30639794
[TBL] [Abstract][Full Text] [Related]
2. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
[TBL] [Abstract][Full Text] [Related]
3. Continuing Low Awareness and Use of Pre-exposure Prophylaxis (PrEP) for HIV among People Who Inject Drugs (PWID), San Francisco, 2022.
Suprasert B; Tate M; Reagan D; Ruiz R; Gao K; McNaughton K; Miller K; Marr A; Taylor KD; Wilson EC; McFarland W
AIDS Behav; 2024 Jun; 28(6):2089-2100. PubMed ID: 38526638
[TBL] [Abstract][Full Text] [Related]
4. The Relationship Between Polysubstance Injection Drug Use, HIV Risk Behaviors, and Interest in Pre-Exposure Prophylaxis (PrEP) Among People Who Inject Drugs in Rural West Virginia.
Schneider KE; White RH; Musci RJ; O'Rourke A; Kilkenny ME; Sherman SG; Allen ST
J Stud Alcohol Drugs; 2020 Nov; 81(6):740-749. PubMed ID: 33308403
[TBL] [Abstract][Full Text] [Related]
5. Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city cross-sectional survey.
Belludi A; McFall AM; Solomon SS; Celentano DD; Mehta SH; Srikrishnan AK; Kumar MS; Solomon S; Lucas GM
PLoS One; 2021; 16(2):e0247352. PubMed ID: 33630909
[TBL] [Abstract][Full Text] [Related]
6. Long-acting Injectable PrEP Interest and General PrEP Awareness among People who Inject Drugs in the San Diego-Tijuana Border Metroplex.
Eger WH; Bazzi AR; Valasek CJ; Vera CF; Harvey-Vera A; Artamonova I; Rangel MG; Strathdee SA; Pines HA
AIDS Behav; 2024 May; 28(5):1650-1661. PubMed ID: 38319461
[TBL] [Abstract][Full Text] [Related]
7. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
[TBL] [Abstract][Full Text] [Related]
8. Factors Associated with Awareness of Pre-exposure Prophylaxis for HIV Among Persons Who Inject Drugs in Philadelphia: National HIV Behavioral Surveillance, 2015.
Roth A; Tran N; Piecara B; Welles S; Shinefeld J; Brady K
AIDS Behav; 2019 Jul; 23(7):1833-1840. PubMed ID: 30267367
[TBL] [Abstract][Full Text] [Related]
9. The role of syringe exchange programs and sexual identity in awareness of pre-exposure prophylaxis (PrEP) for male persons who inject drugs.
Walters SM; Coston B; Neaigus A; Rivera AV; Starbuck L; Ramirez V; Reilly KH; Braunstein SL
Int J Drug Policy; 2020 Mar; 77():102671. PubMed ID: 32092665
[TBL] [Abstract][Full Text] [Related]
10. Differences in Awareness of Pre-exposure Prophylaxis and Post-exposure Prophylaxis Among Groups At-Risk for HIV in New York State: New York City and Long Island, NY, 2011-2013.
Walters SM; Rivera AV; Starbuck L; Reilly KH; Boldon N; Anderson BJ; Braunstein S
J Acquir Immune Defic Syndr; 2017 Jul; 75 Suppl 3():S383-S391. PubMed ID: 28604443
[TBL] [Abstract][Full Text] [Related]
11. Awareness and Correlates of HIV Pre-Exposure Prophylaxis (PrEP) Among HIV-negative People Who Access Syringe Services in Seattle, Washington.
Corcorran MA; Scott JD; Tinsley J; Wald A; Glick SN
Subst Use Misuse; 2022; 57(3):337-343. PubMed ID: 34895022
[TBL] [Abstract][Full Text] [Related]
12. Evidence of Potential Discriminatory HIV Pre-Exposure Prophylaxis (PrEP) Prescribing Practices for People Who Inject Drugs Among a Small Percentage of Providers in the U.S.
Pleuhs B; Mistler CB; Quinn KG; Dickson-Gomez J; Walsh JL; Petroll AE; John SA
J Prim Care Community Health; 2022; 13():21501319211063999. PubMed ID: 35068243
[TBL] [Abstract][Full Text] [Related]
13. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC.
Kuo I; Olsen H; Patrick R; Phillips G; Magnus M; Opoku J; Rawls A; Peterson J; Hamilton F; Kharfen M; Greenberg A
Drug Alcohol Depend; 2016 Jul; 164():8-13. PubMed ID: 27177804
[TBL] [Abstract][Full Text] [Related]
14. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
[TBL] [Abstract][Full Text] [Related]
15. Primary Care Physicians' Willingness to Prescribe HIV Pre-exposure Prophylaxis for People who Inject Drugs.
Edelman EJ; Moore BA; Calabrese SK; Berkenblit G; Cunningham C; Patel V; Phillips K; Tetrault JM; Shah M; Fiellin DA; Blackstock O
AIDS Behav; 2017 Apr; 21(4):1025-1033. PubMed ID: 27896552
[TBL] [Abstract][Full Text] [Related]
16. Factors associated with the uptake of and adherence to HIV pre-exposure prophylaxis in people who have injected drugs: an observational, open-label extension of the Bangkok Tenofovir Study.
Martin M; Vanichseni S; Suntharasamai P; Sangkum U; Mock PA; Chaipung B; Worrajittanon D; Leethochawalit M; Chiamwongpaet S; Kittimunkong S; Gvetadze RJ; McNicholl JM; Paxton LA; Curlin ME; Holtz TH; Samandari T; Choopanya K;
Lancet HIV; 2017 Feb; 4(2):e59-e66. PubMed ID: 27866873
[TBL] [Abstract][Full Text] [Related]
17. Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.
Vincent W; McFarland W
Int J Drug Policy; 2022 Dec; 110():103873. PubMed ID: 36252292
[TBL] [Abstract][Full Text] [Related]
18. Low PrEP Awareness and Use Among People Who Inject Drugs, San Francisco, 2018.
McFarland W; Lin J; Santos GM; Arayasirikul S; Raymond HF; Wilson E
AIDS Behav; 2020 May; 24(5):1290-1293. PubMed ID: 31563984
[TBL] [Abstract][Full Text] [Related]
19. Awareness of and interest in oral pre-exposure prophylaxis (PrEP) for HIV prevention and interest in hypothetical forms of PrEP among people who inject drugs in rural West Virginia.
Schneider KE; White RH; O'Rourke A; Kilkenny ME; Perdue M; Sherman SG; Grieb SM; Allen ST
AIDS Care; 2021 Jun; 33(6):721-728. PubMed ID: 32951438
[TBL] [Abstract][Full Text] [Related]
20. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
